US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.540
  • +0.020+1.32%
Close Dec 24 13:00 ET
10.66MMarket Cap-1.08P/E (TTM)

Biorestorative Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-44.10%-1.7M
-45.31%-1.87M
2.58%-2.32M
-8.75%-6.43M
1.72%-1.59M
18.75%-1.18M
-2.59%-1.28M
-49.21%-2.38M
-77.58%-5.91M
-41.11%-1.62M
Net income from continuing operations
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
21.21%-10.42M
-349.10%-2.3M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
Operating gains losses
84.30%-1.2M
-39.65%1.56M
-221.17%-1.73M
14.61%-4.57M
---923.43K
---7.65M
--2.59M
--1.42M
-133.06%-5.35M
----
Depreciation and amortization
14.53%48.27K
14.88%47.71K
8.54%42.71K
37.49%165.74K
34.34%42.71K
34.97%42.15K
31.77%41.53K
51.29%39.35K
35.28%120.55K
47.91%31.79K
Other non cash items
32.53%38.45K
28.36%37.24K
24.30%36.06K
200.48%90.31K
-95.51%3.28K
0.00%29.01K
0.00%29.01K
113.13%29.01K
-107.07%-89.88K
-22.29%73.09K
Change In working capital
22.92%222.77K
-31.81%192.99K
-510.09%-475.7K
3,543.42%515.33K
138.48%129.06K
266.04%181.23K
9.08%283.01K
-292.09%-77.97K
-95.64%14.14K
-54.75%-335.4K
-Change in receivables
-862.24%-137.6K
184.44%7.6K
---15.7K
70.00%-3.3K
-31.03%20K
50.69%-14.3K
---9K
--0
-191.67%-11K
866.67%29K
-Change in prepaid assets
-46.84%62.16K
301.03%21.1K
13.19%-60.14K
-20.86%57.85K
394.20%20.7K
533.86%116.93K
-106.33%-10.5K
33.45%-69.28K
122.10%73.1K
98.26%-7.04K
-Change in payables and accrued expense
268.69%420.07K
-63.32%123.54K
-1,567.97%-361.08K
421.03%600.1K
144.22%124.77K
26.23%113.94K
173.91%336.8K
-86.64%24.6K
-84.53%115.18K
-233.78%-282.18K
-Change in other current liabilities
-16.50%-41.17K
-16.50%-39.96K
-16.50%-38.78K
14.59%-139.33K
51.58%-36.41K
-17.03%-35.34K
-17.03%-34.3K
-17.03%-33.29K
-61.21%-163.13K
-184.36%-75.19K
Cash from discontinued investing activities
Operating cash flow
-44.10%-1.7M
-45.31%-1.87M
2.58%-2.32M
-8.75%-6.43M
1.72%-1.59M
18.75%-1.18M
-2.59%-1.28M
-49.21%-2.38M
-77.58%-5.91M
-41.11%-1.62M
Investing cash flow
Cash flow from continuing investing activities
4,485.96%936.75K
263.01%2.97M
-294.08%-4.93M
124.27%3.25M
97.39%-84.8K
99.78%-21.36K
694.91%819.03K
2,417.33%2.54M
-43,607.53%-13.4M
-10,480.11%-3.24M
Net PPE purchase and sale
-389.28%-58.46K
-21.51%-35.3K
--0
35.51%-171.04K
-64.45%-70.02K
-148.56%-11.95K
78.90%-29.05K
45.22%-60.02K
-765.10%-265.22K
-38.89%-42.58K
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
---175K
----
Net investment purchase and sale
10,676.11%995.21K
254.74%3.01M
-289.60%-4.93M
126.41%3.42M
99.51%-14.77K
99.91%-9.41K
--848.08K
--2.6M
---12.96M
---3.03M
Cash from discontinued investing activities
Investing cash flow
4,485.96%936.75K
263.01%2.97M
-294.08%-4.93M
124.27%3.25M
97.39%-84.8K
99.78%-21.36K
694.91%819.03K
2,417.33%2.54M
-43,607.53%-13.4M
-10,480.11%-3.24M
Financing cash flow
Cash flow from continuing financing activities
0
-103.12%-12.84K
7.52M
2.35M
83.07K
1.85M
411.7K
0
0
0
Net common stock issuance
--0
----
----
--2.35M
--83.07K
--1.85M
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--7.53M
----
----
--0
--0
--0
----
----
Net other financing activities
--0
---12.84K
---9.54K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-103.12%-12.84K
--7.52M
--2.35M
--83.07K
--1.85M
--411.7K
--0
--0
--0
Net cash flow
Beginning cash position
26.27%2.25M
-36.99%1.16M
-47.25%884.38K
-91.85%1.71M
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-92.03%1.68M
586.11%21.03M
481.84%6.57M
Current changes in cash
-216.78%-762.8K
2,173.28%1.1M
70.55%272.7K
95.71%-829.4K
67.29%-1.59M
105.75%653.22K
96.20%-52.82K
109.38%159.89K
-207.52%-19.31M
-124.42%-4.86M
End cash Position
-38.88%1.49M
26.27%2.25M
-36.99%1.16M
-48.40%884.38K
-48.40%884.38K
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-91.85%1.71M
-91.85%1.71M
Free cash flow
-47.56%-1.76M
-44.79%-1.9M
4.98%-2.32M
-3.90%-6.6M
9.56%-1.66M
16.52%-1.19M
5.49%-1.31M
-43.13%-2.44M
-89.06%-6.35M
-55.93%-1.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -44.10%-1.7M-45.31%-1.87M2.58%-2.32M-8.75%-6.43M1.72%-1.59M18.75%-1.18M-2.59%-1.28M-49.21%-2.38M-77.58%-5.91M-41.11%-1.62M
Net income from continuing operations -122.89%-1.09M29.44%-4.03M69.00%-2.22M21.21%-10.42M-349.10%-2.3M202.41%4.77M-22.12%-5.71M-48.93%-7.17M70.16%-13.22M104.53%924.92K
Operating gains losses 84.30%-1.2M-39.65%1.56M-221.17%-1.73M14.61%-4.57M---923.43K---7.65M--2.59M--1.42M-133.06%-5.35M----
Depreciation and amortization 14.53%48.27K14.88%47.71K8.54%42.71K37.49%165.74K34.34%42.71K34.97%42.15K31.77%41.53K51.29%39.35K35.28%120.55K47.91%31.79K
Other non cash items 32.53%38.45K28.36%37.24K24.30%36.06K200.48%90.31K-95.51%3.28K0.00%29.01K0.00%29.01K113.13%29.01K-107.07%-89.88K-22.29%73.09K
Change In working capital 22.92%222.77K-31.81%192.99K-510.09%-475.7K3,543.42%515.33K138.48%129.06K266.04%181.23K9.08%283.01K-292.09%-77.97K-95.64%14.14K-54.75%-335.4K
-Change in receivables -862.24%-137.6K184.44%7.6K---15.7K70.00%-3.3K-31.03%20K50.69%-14.3K---9K--0-191.67%-11K866.67%29K
-Change in prepaid assets -46.84%62.16K301.03%21.1K13.19%-60.14K-20.86%57.85K394.20%20.7K533.86%116.93K-106.33%-10.5K33.45%-69.28K122.10%73.1K98.26%-7.04K
-Change in payables and accrued expense 268.69%420.07K-63.32%123.54K-1,567.97%-361.08K421.03%600.1K144.22%124.77K26.23%113.94K173.91%336.8K-86.64%24.6K-84.53%115.18K-233.78%-282.18K
-Change in other current liabilities -16.50%-41.17K-16.50%-39.96K-16.50%-38.78K14.59%-139.33K51.58%-36.41K-17.03%-35.34K-17.03%-34.3K-17.03%-33.29K-61.21%-163.13K-184.36%-75.19K
Cash from discontinued investing activities
Operating cash flow -44.10%-1.7M-45.31%-1.87M2.58%-2.32M-8.75%-6.43M1.72%-1.59M18.75%-1.18M-2.59%-1.28M-49.21%-2.38M-77.58%-5.91M-41.11%-1.62M
Investing cash flow
Cash flow from continuing investing activities 4,485.96%936.75K263.01%2.97M-294.08%-4.93M124.27%3.25M97.39%-84.8K99.78%-21.36K694.91%819.03K2,417.33%2.54M-43,607.53%-13.4M-10,480.11%-3.24M
Net PPE purchase and sale -389.28%-58.46K-21.51%-35.3K--035.51%-171.04K-64.45%-70.02K-148.56%-11.95K78.90%-29.05K45.22%-60.02K-765.10%-265.22K-38.89%-42.58K
Net intangibles purchase and sale --------------0-------------------175K----
Net investment purchase and sale 10,676.11%995.21K254.74%3.01M-289.60%-4.93M126.41%3.42M99.51%-14.77K99.91%-9.41K--848.08K--2.6M---12.96M---3.03M
Cash from discontinued investing activities
Investing cash flow 4,485.96%936.75K263.01%2.97M-294.08%-4.93M124.27%3.25M97.39%-84.8K99.78%-21.36K694.91%819.03K2,417.33%2.54M-43,607.53%-13.4M-10,480.11%-3.24M
Financing cash flow
Cash flow from continuing financing activities 0-103.12%-12.84K7.52M2.35M83.07K1.85M411.7K000
Net common stock issuance --0----------2.35M--83.07K--1.85M----------0--0
Proceeds from stock option exercised by employees --0--0--7.53M----------0--0--0--------
Net other financing activities --0---12.84K---9.54K----------------------------
Cash from discontinued financing activities
Financing cash flow --0-103.12%-12.84K--7.52M--2.35M--83.07K--1.85M--411.7K--0--0--0
Net cash flow
Beginning cash position 26.27%2.25M-36.99%1.16M-47.25%884.38K-91.85%1.71M-62.93%2.44M-90.05%1.78M-90.50%1.84M-92.03%1.68M586.11%21.03M481.84%6.57M
Current changes in cash -216.78%-762.8K2,173.28%1.1M70.55%272.7K95.71%-829.4K67.29%-1.59M105.75%653.22K96.20%-52.82K109.38%159.89K-207.52%-19.31M-124.42%-4.86M
End cash Position -38.88%1.49M26.27%2.25M-36.99%1.16M-48.40%884.38K-48.40%884.38K-62.93%2.44M-90.05%1.78M-90.50%1.84M-91.85%1.71M-91.85%1.71M
Free cash flow -47.56%-1.76M-44.79%-1.9M4.98%-2.32M-3.90%-6.6M9.56%-1.66M16.52%-1.19M5.49%-1.31M-43.13%-2.44M-89.06%-6.35M-55.93%-1.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+7.81%
Tesla
TSLA
+7.36%
MARA Holdings
MARA
+4.68%
Coinbase
COIN
+4.28%
Amazon
AMZN
+1.77%

Unlock the Full List